Exactly, and most who saw the Big Short just dismiss it as entertainment, and don't care about the implications, but you and know better.
Clown show is a good way of describing the blatant, incessant manipulation that goes on in every market, options, oil, heavily shorted names, all of it.. It's just amazing how the SEC doesn't get involved with any part of the clown show.
and now I can't pull it up, the link no longer works. Gee, I wonder why. On a related note, I think we'll test $16 on Monday or Tuesday. It'll be really interesting to see how RLYP trades up to Thurs.
This is the part where you wish you had unlimited funds at your disposal. Memo to longs...in this scenario, you really don't want to sell, even with the run up. It's obvious to me with the volume, a fund is taking a large position early, before the real fireworks....all in my opinion of course.
1. The Kremer's integration is going well, and they're still negotiating with the client Kremers lost, to bring them back
2. Even without no. 1 above, they already feel they're close to replacing that customer's revenue
3. They recently announced a huge partnership to develop the generic insulin market, a market in the billions
4. They were very upbeat on the recent ER call
5. Some analysts believe LCI could be a great M&A candidate, fitting in nicely with a larger generic player's acquisition strategy.
6. Technically the stock broke out late last week, so now you have some health care funds getting in early
Did I leave anything out?
Read my thread below yours....I think something big is up, or as I've suggested the market is repricing this stock quickly, as it's very undervalued.
In fact, there may be more going on than we're currently aware of, e.g. the arbitrage guys getting the heads up on an M&A play....
The technical indicators continue to turn up. Yesterday's supply was met with immediate demand, and the trend continues today (Friday). It looks like we could trade close to $24 by as soon as next week.
Great article, thanks. Read the comments section as well. And it was written after the AZN ZSPH acquisition. Next Thursday or Friday should be very interesting.
I suggest you cover your short before next week. Every one of your posts supports the fact that you're short the stock.
"The SP is going to take a hit with any kind of ZS-9 approval." The SP has taken a huge hit already, anticipating the competitor's approval, i.e. it's already in the SP. Therefore , the surprise is not the approval, it's the labeling or other issues. If anything, the SP will go UP, regardless of the result next week, because the uncertainty will be removed.
Why is that the "lone saving grace", when we have an FDA approved, first mover drug advantage already on the market? The market opportunity is huge, and there's certainly room for more than one player. It's really mind boggling to me that this stock has been hammered this much, with such a high short interest. At this point, one would have to think a clean, no BB approval for ZS-9 is already baked into this low SP.